Skip to content

Mid-Term Natural Course Postoperative of Crowe Type III-IV Hip Dysplasia

Mid-Term Natural Course of Lower Extremity and Spine After Total Hip Arthroplasty in Patients With Crowe Type III-IV Hip Dysplasia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05149729
Enrollment
20
Registered
2021-12-08
Start date
2021-02-10
Completion date
2024-06-10
Last updated
2021-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthropathy, Hip Dysplasia

Brief summary

Comparison of preoperative and postoperative mid-term course of patients with Crowe Type 3 and Type 4 hip dysplasia.

Detailed description

Crowe type 3 and type 4 patients who underwent shortened hip replacement surgery will be followed up for 2 years. Patients will be called for routine outpatient controls at the 2nd week, 6th week, 3rd month, 6th month, 12th month, 24th month. Patients will be referred to the physical therapy specialist for abduction strengthening and pelvis tilt corrective exercises starting from the 6th week. Scoliosis and orthoroentgenography x-rays will be taken at the last control of the patients. HHS, WOMAC hip score and SF-12 score will be obtained from the patients. Scores, lower extremity and spine angles will be evaluated after the last examinations performed at 12 and 24 months.

Interventions

PROCEDUREShortened hip arthroplasty

Crowe type 3 and 4 patients who underwent shortened hip prosthesis

Sponsors

Bezmialem Vakif University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients over the age of 18 who underwent Crowe Type 3 and Type 4 shortened hip prosthesis

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Crowe type 3 and 4 patients over 18 years of age who had shortened hip replacement surgery

Exclusion criteria

* Crowe type 1 or 2 patients over 18 years of age who had shortened hip replacement surgery * Patients who have previously operated on the contralateral hip * Patients who underwent shortened hip replacement for a reason other than developmental dysplasia of the hip

Design outcomes

Primary

MeasureTime frameDescription
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)The degree of improvement in Vomac score will be evaluated by looking at preoperative and postoperative 12th month Vomac scores.( 0-12th month )The WOMAC score range, which indicates the clinical satisfaction of the patients, is between 0-100.

Countries

Turkey (Türkiye)

Contacts

Primary Contacthakan batuhan kaya
hbatuhan-kaya-123@hotmail.com00905542294339

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026